Pep Charusanti

8.4k total citations · 1 hit paper
30 papers, 2.4k citations indexed

About

Pep Charusanti is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Pep Charusanti has authored 30 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 9 papers in Pharmacology and 9 papers in Genetics. Recurrent topics in Pep Charusanti's work include Microbial Metabolic Engineering and Bioproduction (13 papers), Genomics and Phylogenetic Studies (10 papers) and Microbial Natural Products and Biosynthesis (9 papers). Pep Charusanti is often cited by papers focused on Microbial Metabolic Engineering and Bioproduction (13 papers), Genomics and Phylogenetic Studies (10 papers) and Microbial Natural Products and Biosynthesis (9 papers). Pep Charusanti collaborates with scholars based in United States, Denmark and South Korea. Pep Charusanti's co-authors include Sang Yup Lee, Bernhard Ø. Palsson, Tilmann Weber, Yaojun Tong, Hyun Uk Kim, Lixin Zhang, Joshua A. Lerman, Xinglin Jiang, Tom M Conrad and Kai Blin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Pep Charusanti

30 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Omic data from evolved E. coli are consistent with computed optimal growth from genome‐scale models

2010 527 citations Nathan E. Lewis, Kim Hixson et al. Molecular Systems Biology profile →

Peers

Countries citing papers authored by Pep Charusanti

Since Specialization

Citations

This map shows the geographic impact of Pep Charusanti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pep Charusanti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pep Charusanti more than expected).

Fields of papers citing papers by Pep Charusanti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pep Charusanti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pep Charusanti. The network helps show where Pep Charusanti may publish in the future.

Co-authorship network of co-authors of Pep Charusanti

This figure shows the co-authorship network connecting the top 25 collaborators of Pep Charusanti. A scholar is included among the top collaborators of Pep Charusanti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pep Charusanti. Pep Charusanti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pangenome mining of the Streptomyces genus redefines species’ biosynthetic potential 2025 ·Genome biology ·Omkar S. Mohite, Tue Sparholt Jørgensen, Thomas Booth, Pep Charusanti, Patrick V. Phaneuf, Tilmann Weber, Bernhard Ø. Palsson	4
2	Maramycin, a Cytotoxic Isoquinolinequinone Terpenoid Produced through Heterologous Expression of a Bifunctional Indole Prenyltransferase/Tryptophan Indole-Lyase in S. albidoflavus 2024 ·ACS Chemical Biology ·(unknown), Mario Wibowo, Sam E. Williams, Charlotte H. Gotfredsen, (unknown), (unknown), (unknown), Pep Charusanti, Tetiana Gren, Subhasish Saha, José M.A. Moreira, Tilmann Weber, Ling Ding	3
3	Complete, circular genome sequence of a Bosea sp . isolate from soil 2023 ·Microbiology Resource Announcements ·(unknown), (unknown), (unknown), (unknown), Pep Charusanti, Tue Sparholt Jørgensen, Tilmann Weber	2
4	Programmable polyketide biosynthesis platform for production of aromatic compounds in yeast 2020 ·Synthetic and Systems Biotechnology ·Tadas Jakočiūnas, Andreas Klitgaard, (unknown), Julie B. Nielsen, (unknown), (unknown), Kai Blin, Christopher J. Petzold, Jennifer Gin, Yaojun Tong, Charlotte H. Gotfredsen, Pep Charusanti, Rasmus John Normand Frandsen, Tilmann Weber, Sang Yup Lee, Michael K. Jensen, Jay D. Keasling	19
5	Dissemination of antibiotic resistance genes from antibiotic producers to pathogens 2017 ·Nature Communications ·Xinglin Jiang, Mostafa M. H. Ellabaan, Pep Charusanti, Christian Munck, Kai Blin, Yaojun Tong, Tilmann Weber, Morten Otto Alexander Sommer, Sang Yup Lee	326
6	The aldehyde dehydrogenase, AldA, is essential for L-1,2-propanediol utilization in laboratory-evolved Escherichia coli 2016 ·Microbiological Research ·Ramy K. Aziz, Jonathan M. Monk, (unknown), (unknown), (unknown), (unknown), Bernhard Ø. Palsson, Pep Charusanti	6
7	Model-driven discovery of synergistic inhibitors against E. coli and S. enterica serovar Typhimurium targeting a novel synthetic lethal pair, aldA and prpC 2015 ·Frontiers in Microbiology ·Ramy K. Aziz, (unknown), Jonathan M. Monk, Elizabeth Brunk, Robert M. Lewis, (unknown), Arti Mishra, (unknown), Chitkala Satyanarayana, Saravanakumar Dhakshinamoorthy, (unknown), Douglas B. Kitchen, (unknown), Bernhard Ø. Palsson, Pep Charusanti	7
8	CRISPR-Cas9 Based Engineering of Actinomycetal Genomes 2015 ·ACS Synthetic Biology ·Yaojun Tong, Pep Charusanti, Lixin Zhang, Tilmann Weber, Sang Yup Lee	330
9	Metabolic engineering of antibiotic factories: new tools for antibiotic production in actinomycetes 2014 ·Trends in biotechnology ·Tilmann Weber, Pep Charusanti, Ewa Maria Musiol-Kroll, Xinglin Jiang, Yaojun Tong, Hyun Uk Kim, Sang Yup Lee	153
10	Understanding system dynamics of an adaptive enzyme network from globally profiled kinetic parameters 2014 ·BMC Systems Biology ·Austin W.T. Chiang, Wei‐Chung Liu, Pep Charusanti, Ming‐Jing Hwang	18
11	Capsule deletion via a λ-Red knockout system perturbs biofilm formation and fimbriae expression in Klebsiella pneumoniae MGH 78578 2014 ·BMC Research Notes ·Tzu‐Wen Huang, (unknown), Hwan‐You Chang, Shih-Feng Tsai, Bernhard Ø. Palsson, Pep Charusanti	67
12	A Gapless, Unambiguous Genome Sequence of the Enterohemorrhagic Escherichia coli O157:H7 Strain EDL933 2014 ·Genome Announcements ·Haythem Latif, Howard J. Li, Pep Charusanti, Bernhard Ø. Palsson, Ramy K. Aziz	47
13	Systems biology and biotechnology of Streptomyces species for the production of secondary metabolites 2013 ·Biotechnology Advances ·(unknown), Hyun Uk Kim, Pep Charusanti, Bernhard Ø. Palsson, Sang Yup Lee	165
14	Multiple-omic data analysis of Klebsiella pneumoniae MGH 78578 reveals its transcriptional architecture and regulatory features 2012 ·BMC Genomics ·Joo‐Hyun Seo, (unknown), Donghyuk Kim, Byung‐Kwan Cho, Tzu‐Wen Huang, Shih‐Feng Tsai, Bernhard Ø. Palsson, Pep Charusanti	31
15	Exploiting Adaptive Laboratory Evolution of Streptomyces clavuligerus for Antibiotic Discovery and Overproduction 2012 ·PLoS ONE ·Pep Charusanti, Nicole L. Fong, Harish Nagarajan, Albán R. Pereira, Howard J. Li, (unknown), Yongxuan Su, William H. Gerwick, Bernhard Ø. Palsson	67
16	An Experimentally Validated Genome-Scale Metabolic Reconstruction of Klebsiella pneumoniae MGH 78578, i YL1228 2011 ·Journal of Bacteriology ·Yu-Chieh Liao, Tzu‐Wen Huang, (unknown), Pep Charusanti, (unknown), Hwan‐You Chang, Shih-Feng Tsai, Bernhard Ø. Palsson, Chao A. Hsiung	95
17	An experimentally-supported genome-scale metabolic network reconstruction for Yersinia pestis CO92 2011 ·BMC Systems Biology ·Pep Charusanti, Sadhana Chauhan, (unknown), Joshua A. Lerman, Daniel R. Hyduke, Vladimir L. Motin, Charles Ansong, Joshua Adkins, Bernhard Ø. Palsson	35
18	Genetic Basis of Growth Adaptation of Escherichia coli after Deletion of pgi, a Major Metabolic Gene 2010 ·PLoS Genetics ·Pep Charusanti, Tom M Conrad, Eric M. Knight, (unknown), Nicole L. Fong, Bin Xie, Yuan Gao, Bernhard Ø. Palsson	106
19	Omic data from evolved E. coli are consistent with computed optimal growth from genome‐scale models breakdown → 2010 ·Molecular Systems Biology ·Nathan E. Lewis, Kim Hixson, Tom M Conrad, Joshua A. Lerman, Pep Charusanti, Ashoka D. Polpitiya, Joshua Adkins, Gunnar Schramm, Samuel Purvine, Daniel López‐Ferrer, Karl Weitz, Roland Eils, Rainer König, Richard Smith, Bernhard Ø. Palsson	527
20	Microbial regulatory and metabolic networks 2007 ·Current Opinion in Biotechnology ·Byung‐Kwan Cho, Pep Charusanti, Markus J. Herrgård, Bernhard Ø. Palsson	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact